A Novel Cancer Therapeutic Using Thrombospondin 1 in Dendritic Cells

doi:10.1038/mt.2013.236

Chia Nan University of Pharmacy & Science Institutional Repository > 智慧生活學院 > 高齡福祉養生管理系 > 期刊論文 > Item 310902800/28489

請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/28489

標題:	A Novel Cancer Therapeutic Using Thrombospondin 1 in Dendritic Cells
作者:	Weng, Tzu-Yang Huang, Shih-Shien Yen, Meng-Chi Lin, Chi-Chen Chen, Yi-Ling Lin, Chiu-Mei Chen, Wei-Ching Wang, Chih-Yang Chang, Jang-Yang Lai, Ming-Derg
貢獻者:	老人服務事業管理系
關鍵字:	REGULATORY T-CELLS IN-VIVO INDOLEAMINE 2,3-DIOXYGENASE ENDOTHELIAL-CELLS TYPE-1 REPEATS SKIN DELIVERY DNA VACCINE TGF-BETA ANTIGEN INFLAMMATION
日期:	2014-02
上傳時間:	2015-05-06 21:18:08 (UTC+8)
出版者:	Nature Publishing Group
摘要:	Induction of thrombospondin 1 (TSP-1) is generally assumed to suppress tumor growth through inhibiting angiogenesis; however, it is less clear how TSP-1 in dendritic cells (DCs) influences tumor progression. We investigated tumor growth and immune mechanism by downregulation of TSP-1 in dendritic cells. Administration of TSP-1 small hairpin RNA (shRNA) through the skin produced anticancer therapeutic effects. Tumorinfiltrating CD4(+) and CD8(+) T cells were increased after the administration of TSP-1 shRNA. The expression of interleukin-12 and interferon-7 in the lymph nodes was enhanced by injection of TSP-1 shRNA. Lymphocytes from the mice injected with TSP-1 shRNA selectively killed the tumor cells, and the cytotoxicity of lymphocytes was abolished by depletion of CD8(+) T cells. Injection of CD11c(+) TSP-1 knockout (TSP-1-KO) bone marrow derived DCs (BMDCs) delayed tumor growth in tumorbearing mice. Similarly, antitumor activity induced by TSP-1-K0 BMDCs was abrogated by depletion of CD8(+) T cells. In contrast, the administration of shRNAs targeting TSP-2, another TSP family member, did not extend the survival of tumor-bearing mice. Finally, TSP-1 shRNA functioned as an innmunotherapeutic adjuvant to augment the therapeutic efficacy of Neu DNA vaccination. Collectively, the downregulation of TSP-1 in DCs produces an effective antitumor response that is opposite to the protumor effects by silencing of TSP-1 within tumor cells.
關聯:	Molecular therapy, v.22 n.2, pp.292-302
顯示於類別:	[高齡福祉養生管理系] 期刊論文

文件中的檔案:

檔案	描述	大小	格式	瀏覽次數
index.html		0Kb	HTML	1692	檢視/開啟

在CNU IR中所有的資料項目都受到原著作權保護.

TAIR相關文章

資料載入中.....